84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]李文雄,張晶宇,楊鋒.中藥調(diào)控骨髓間充質(zhì)干細(xì)胞成骨分化的研究進(jìn)展[J].中醫(yī)正骨,2016,28(07):68-71.
點(diǎn)擊復(fù)制

中藥調(diào)控骨髓間充質(zhì)干細(xì)胞成骨分化的研究進(jìn)展()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期數(shù):
2016年07期
頁碼:
68-71
欄目:
綜 述
出版日期:
2016-07-20

文章信息/Info

作者:
李文雄1張晶宇1楊鋒2
1.陜西中醫(yī)藥大學(xué); 陜西 咸陽 712000; 2.陜西中醫(yī)藥大學(xué)附屬醫(yī)院,陜西 咸陽 712083
關(guān)鍵詞:
間質(zhì)干細(xì)胞 干細(xì)胞研究 細(xì)胞分化 成骨細(xì)胞 軟骨細(xì)胞 中草藥 綜述
摘要:
骨髓間充質(zhì)干細(xì)胞(bone marrow mesenchymal stem cells,BMSCs)在一定的誘導(dǎo)條件下能夠分化為成骨細(xì)胞、軟骨細(xì)胞等成熟細(xì)胞。關(guān)于BMSCs定向分化的研究一直是干細(xì)胞研究領(lǐng)域的熱點(diǎn)和難點(diǎn)。BMSCs成骨分化與中醫(yī)“腎藏精,主骨生髓”理論具有相通性,應(yīng)用中藥誘導(dǎo)干細(xì)胞分化具有良好的前景。本文從理論基礎(chǔ)、具體的調(diào)控作用以及可能的作用機(jī)制3個(gè)方面,對近年來中藥調(diào)控BMSCs成骨分化的研究進(jìn)展進(jìn)行了綜述。

參考文獻(xiàn)/References:

[1] Arpornmaeklong P,Brown SE,Wang Z,et al.Phenotypic characterization,osteoblastic differentiation,and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells[J].Stem Cells Dev,2009,18(7):955-968. [2] 胡丹,黃秋云,黎金濃,等.中藥誘導(dǎo)骨髓間充質(zhì)干細(xì)胞多向分化研究進(jìn)展[J].中華細(xì)胞與干細(xì)胞雜志:電子版,2013,3(4):218-222. [3] 卞琴,黃建華,楊鑄,等.三種補(bǔ)腎中藥有效成分對皮質(zhì)酮致骨質(zhì)疏松大鼠骨髓間充質(zhì)干細(xì)胞基因表達(dá)譜的作用[J].中西醫(yī)結(jié)合學(xué)報(bào),2011,9(2):179-185. [4] Kisiday JD,Goodrich LR,Mcilwraith CW,et al.Effects of equine bone marrow aspirate volume on isolation,proliferation,and differentiation potential of mesenchymal stem cells[J].Am J Vet Res,2013,74(5):801-807. [5] Mimeault M,Hauke R,Batra SK.Stem cells:a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies[J].Clin Pharmacol Ther,2007,82(3):252-264. [6] 李丹青,肖強(qiáng)兵.巴戟天多糖通過p38 MAPK信號通路促間充質(zhì)干細(xì)胞成骨分化的體外研究[J].中國中醫(yī)骨傷科雜志,2015,23(5):1-4. [7] 李楠,王和鳴,郭素華,等.巴戟天多糖對體外培養(yǎng)成骨細(xì)胞核心結(jié)合因子α1mRNA表達(dá)的影響[J].中華中醫(yī)藥雜志,2007,22(8):517-519. [8] 陳林攀,鄧鳴濤,杜川,等.杜仲葉提取物槲皮素通過激活ERK磷酸化促進(jìn)BMSCs增殖的研究[J].時(shí)珍國醫(yī)國藥,2014,25(12):2845-2847. [9] 張甲第,時(shí)舒曼,張海洋,等.銀杏葉提取物對骨髓間充質(zhì)干細(xì)胞增殖及成骨分化的影響[J].口腔醫(yī)學(xué)研究,2015,31(6):575-579. [10] 舒曉春,朱丹華,龐天嬌,等.骨碎補(bǔ)總黃酮在不同糖濃度下對大鼠骨髓間充質(zhì)干細(xì)胞成骨分化的影響[J].中華醫(yī)學(xué)雜志,2010,90(38):2708-2712. [11] 劉琳,白海,王存邦,等.黃芪多糖對多發(fā)性骨髓瘤患者骨髓間充質(zhì)干細(xì)胞增殖與細(xì)胞因子表達(dá)的影響[J].現(xiàn)代生物醫(yī)學(xué)進(jìn)展,2013,13(10):1873-1877. [12] Yang F,Yuan PW,Hao YQ,et al.Emodin enhances osteogenesis and inhibits adipogenesis[J].Bmc Complementary & Alternative Medicine,2014,14(1):1-9. [13] 楊鋒,李小群,楊利學(xué),等.右歸丸含藥血清對骨髓間充質(zhì)干細(xì)胞成骨及成脂分化的影響[J].中華中醫(yī)藥志,2015,30(1):263-266. [14] 楊鋒,潘樂,馬秋濤,等.左歸丸對骨髓間充質(zhì)干細(xì)胞成骨分化相關(guān)基因甲基化的影響[J].中醫(yī)雜志,2015,56(15):1326-1329. [15] 郭楊,馬勇,成吉華,等.益腎通絡(luò)復(fù)方含藥血清對兔骨髓間充質(zhì)干細(xì)胞體外增殖和成骨分化的影響[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2015,21(5):508-510. [16] 陳德強(qiáng),劉鵬飛,王鑫.虎潛丸對骨髓基質(zhì)干細(xì)胞增殖及分化的影響[J].山東中醫(yī)雜志,2012,31(1):50-54. [17] 梁祖建,吳春飛,張百擋.補(bǔ)腎調(diào)肝方誘導(dǎo)衰老BMSCs成骨分化的實(shí)驗(yàn)研究[J].中國骨質(zhì)疏松雜志,2013,19(3):212-216. [18] 徐世紅,謝興文,李寧,等.桃紅四物湯含藥血清對骨髓間充質(zhì)干細(xì)胞增殖、成骨分化的影響[J].中華中醫(yī)藥雜志,2013,28(9):2713-2716. [19] Islam SS,Mokhtari RB,Kumar S,et al.Spatio-Temporal Distribution of Smads and Role of Smads/TGF-β/BMP-4 in the Regulation of Mouse Bladder Organogenesis[J].PLoS One,2013,8(4):e61340. [20] Katagiri T,Tsukamoto S.The unique activity of bone morphogenetic proteins in bone:a critical role of the Smad signaling pathway[J].Biol Chem,2013,394(6):703-714. [21] Aenlle KK,Curtis KM,Roos BA,et al.Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells[J].Mol Endocrinol,2014,28(5):722-730.

相似文獻(xiàn)/References:

[1]吳剛,童培建.補(bǔ)腎活血湯含藥血清干預(yù)體外培養(yǎng)大鼠骨髓間充質(zhì)干細(xì)胞成軟骨分化及補(bǔ)腎活血湯聯(lián)合骨髓間充質(zhì)干細(xì)胞治療大鼠膝骨關(guān)節(jié)炎的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2018,30(01):6.
 WU Gang,TONG Peijian.Impact of Bushen Huoxue Tang(補(bǔ)腎活血湯)medicated serum on chondrogenic differentiation?of rat’s bone marrow derived mesenchymal stem cells cultured in vitro[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(07):6.
[2]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學(xué)概況及發(fā)病機(jī)制研究進(jìn)展[J].中醫(yī)正骨,2018,30(03):52.
[3]陸吳超,錢偉宏,姚志宏,等.補(bǔ)腎、活血中藥及補(bǔ)腎活血復(fù)方對骨髓間充質(zhì)干細(xì)胞增殖、定向遷移及成骨分化的影響及作用機(jī)制的研究進(jìn)展[J].中醫(yī)正骨,2018,30(07):36.
[4]梅滿,于波.微重力影響間充質(zhì)干細(xì)胞向軟骨細(xì)胞分化的研究進(jìn)展[J].中醫(yī)正骨,2019,31(01):38.
[5]張厚建,張維新,童培建.間充質(zhì)干細(xì)胞來源外泌體治療骨關(guān)節(jié)炎和軟骨損傷的研究進(jìn)展[J].中醫(yī)正骨,2020,32(06):49.
[6]孫曉輝,趙斌,劉洋,等.負(fù)載microRNA-27b-骨髓間充質(zhì)干細(xì)胞來源外泌體的軟骨細(xì)胞-聚乳酸羥基乙酸共聚物骨軟骨復(fù)合體移植治療軟骨缺損的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2021,33(01):1.
 SUN Xiaohui,ZHAO Bin,LIU Yang,et al.MicroRNA-27b-bone marrow mesenchymal stem cell derived exosomes-laden chondrocytes-poly(lactic-co-glycolic acid)osteochondral complex transplantation for treatment of osteochondral defects:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(07):1.
[7]吳叢姿,金紅婷,童培建.從髓論治膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2021,33(01):52.
[8]沈紹寧,吳東曉,呂帥潔,等.干細(xì)胞療法在血友病性關(guān)節(jié)炎治療中的應(yīng)用進(jìn)展…[J].中醫(yī)正骨,2021,33(07):33.
 SHEN Shaoning,WU Dongxiao,LYU Shuaijie,et al.Advancement of application of stem cell therapy in treatment of hemophilic arthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(07):33.
[9]趙軍,孔令俊,王興盛,等.物理療法調(diào)控骨髓間充質(zhì)干細(xì)胞成骨分化治療骨質(zhì)疏松癥的研究進(jìn)展[J].中醫(yī)正骨,2022,34(07):54.
[10]劉朝輝,鄧葉龍,孔令俊,等.脈沖電磁場對骨髓間充質(zhì)干細(xì)胞成骨分化影響的研究進(jìn)展[J].中醫(yī)正骨,2023,35(04):38.

備注/Memo

備注/Memo:
2016-04-05收稿 2016-05-04修回
基金項(xiàng)目:國家自然科學(xué)基金面上項(xiàng)目(81102610,81473711); 陜西省社會(huì)發(fā)展科技攻關(guān)項(xiàng)目(2015SF072); 陜西省中醫(yī)管理局中醫(yī)藥科研課題中標(biāo)項(xiàng)目(13-JC014)
楊鋒 E-mail:[email protected]

更新日期/Last Update: 1900-01-01